Viz ai, an AI-powered disease detection and intelligent care coordination, has announced the launch of a new real-time clinical intelligence service for Salesforce’s Agentforce Life Sciences. The offering is designed to power new and existing agentic solutions for life sciences customers, including a data integration that brings Viz ai’s real-time data, triggers and clinical intelligence layer into Agentforce from a network of nearly 2,000 hospitals covering approximately 230 million lives across the United States.
The integration enables life science companies to deploy intelligent, timely, closed-loop agentic workflows that orchestrate guideline-based, next-best actions across commercial, medical and patient support teams. It also unlocks new point-of-care agents that can better educate, activate and support clinicians and patients at critical moments in the care journey.
As life sciences go-to-market success increasingly depends on navigating complex patient journeys, educating clinicians at key decision points and aligning sales representatives, Medical Science Liaisons (MSLs) and digital channels, fragmented or delayed clinical and market signals have posed major challenges. Viz ai’s service for Agentforce Life Sciences aims to address these gaps by unifying clinical and customer context, embedding compliant workflows and enabling coordinated, agent-driven engagement that delivers measurable impact at the point of care.
Mark Sullivan, President and Chief Revenue Officer for Salesforce Regulated Industries, said, “Pharma companies are shifting from volume to value, and they need real-time intelligence, compliant orchestration and deep market insight to serve clinicians and patients effectively. Together, Viz ai and Salesforce are enabling this transformation and creating a closed-loop, agentic model where Agentforce Life Sciences agents become more context-aware and effective, operating at the point of care to educate, activate and support clinicians and patients when it matters most.”
Agentforce offers a library of ready-to-use skills packaged topics and actions designed to accelerate work execution—including skills from Viz ai available via the AppExchange. These skills are grounded in an organisation’s data and metadata and are supported by what Salesforce describes as the first enterprise ecosystem of agent skills, allowing partners and customers to extend Agentforce with custom topics, actions and agent types.
Chris Mansi, CEO and co-founder of Viz ai, said, “This collaboration reimagines pharma go-to-market as an always-on, point-of-care operating system, where real-time clinical moments are instantly translated into actionable intelligence. For the first time, real-time clinical events inside hospitals can seamlessly trigger the right educational, medical, or commercial engagement at scale. By connecting Viz ai’s agents and evidence with Agentforce Life Sciences, we are creating a modern foundation for how pharmaceutical companies support clinicians and patients.”
Through the Agentforce Life Sciences and Viz ai Data 360 connector, customers can convert real-time clinical moments into guideline-based, next-best actions across sales, MSLs, marketing, market access and patient services. The integration also enables agentic, point-of-care clinician engagement by leveraging Viz ai’s proprietary real-time clinician-level signals to deliver compliant, in-workflow education and evidence. In addition, life sciences organisations can activate patient onboarding and access support immediately at the point of care, including enrollment and HUB referrals, benefits verification, copay assistance and prior authorisation barrier mitigation, helping reduce drop-offs and improve conversion from decision to treatment initiation.
The closed-loop system further allows organisations to continuously improve performance by feeding in-workflow engagement and outcomes back into CRM systems, refining targeting strategies, patient journeys and messaging over time.
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy